Global Fibrate Drugs Market, By Drugs (Clofibrate, Gemfibrozil, Fenofibrate, Others), Indication (Hypercholesterolemia, Heart Attacks, Others), End-Users (Hospitals, Homecare, Specialty Clinics, ...

This is the most recent version of the national Cancer Drugs Fund list, and replaces any earlier versions. It contains updates to the previous list, as well as new drugs and indications which have ...

We offer both traditional, research-intensive graduate programs in Pharmacology and Physiology (MS and PhD) and a professional program in Drug Discovery and Development (MS). The Drexel Drug Discovery ...

In conclusion, silymarin is a well tolerated and effective antidote for use in hepatotoxicity produced by a number of toxins, including A phalloides, ethanol and psychotropic drugs. Numerous ...

with the goal of achieving a therapeutic outcome. Issues of pharmacodynamics and pharmacokinetics are important considerations for drug delivery.

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Design characteristics of included trials were presented in Table 2. The trials compared fibrate therapy with placebo were included in our research. Sample size of the trials ranged from 95 to ...

Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing ...

PPARα is a target for the hypolipidemic drugs of the fibrate family. PPARα is less expressed in the liver of patients with non-alcoholic fatty liver diseases (NAFLD). Several PPAR-targeting molecules, ...